- Home
- CBOE vs TEVA Comparison
CBOE vs TEVA Comparison
Compare CBOE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBOE
- TEVA
- Stock Information
- Founded
- CBOE 1973
- TEVA 1901
- Country
- CBOE United States
- TEVA Israel
- Employees
- CBOE N/A
- TEVA N/A
- Industry
- CBOE Investment Bankers/Brokers/Service
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CBOE Finance
- TEVA Health Care
- Exchange
- CBOE Nasdaq
- TEVA Nasdaq
- Market Cap
- CBOE 23.7B
- TEVA 20.1B
- IPO Year
- CBOE 2010
- TEVA N/A
- Fundamental
- Price
- CBOE $235.29
- TEVA $16.41
- Analyst Decision
- CBOE Hold
- TEVA Strong Buy
- Analyst Count
- CBOE 14
- TEVA 7
- Target Price
- CBOE $224.71
- TEVA $24.71
- AVG Volume (30 Days)
- CBOE 624.2K
- TEVA 10.0M
- Earning Date
- CBOE 08-01-2025
- TEVA 07-30-2025
- Dividend Yield
- CBOE 1.07%
- TEVA N/A
- EPS Growth
- CBOE 2.12
- TEVA N/A
- EPS
- CBOE 7.62
- TEVA N/A
- Revenue
- CBOE $4,332,300,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- CBOE N/A
- TEVA $5.69
- Revenue Next Year
- CBOE $4.18
- TEVA N/A
- P/E Ratio
- CBOE $30.90
- TEVA N/A
- Revenue Growth
- CBOE 15.76
- TEVA 3.82
- 52 Week Low
- CBOE $168.16
- TEVA $12.47
- 52 Week High
- CBOE $237.27
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CBOE 60.85
- TEVA 41.31
- Support Level
- CBOE $230.26
- TEVA $16.55
- Resistance Level
- CBOE $237.27
- TEVA $17.07
- Average True Range (ATR)
- CBOE 4.82
- TEVA 0.37
- MACD
- CBOE 0.40
- TEVA -0.08
- Stochastic Oscillator
- CBOE 85.58
- TEVA 9.29
About CBOE Cboe Global Markets Inc.
Cboe Global Markets Inc is a provider of market infrastructure and tradable products, that delivers cutting-edge trading, clearing, and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive all over world marketplace, and to providing products, technology, and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.